| 日期 | 主要股東
| 每股
平均價 | 類型 | 買/賣或涉及
股份數目 | 變動股數
佔已發行股(%) | 目前持股量 | 佔已
發行股(%) |
| 2020-07-17 | 摩根大通 | 141.804 | 1205 (L)
N/A
N/A | 1,545,817(L)
N/A
N/A | N/A
N/A
N/A | 80121192(L)
5689894(S)
73156855(P) | 6.89(L)
0.48(S)
6.29(P) |
| 2020-07-17 | Amgen Inc. | | 1316 (L) | 29,614,832(L) | N/A | 236249845(L) | 20.31(L) |
| 2020-07-17 | Baker Julian Charles | | 1316 (L) | 19,880,419(L) | N/A | 174056354(L) | 14.96(L) |
| 2020-07-17 | Baker Felix James | | 1316 (L) | 19,880,419(L) | N/A | 174056354(L) | 14.96(L) |
| 2020-07-16 | 摩根大通 | 138.637 | 1104 (L)
N/A
N/A | 1,290,600(L)
N/A
N/A | N/A
N/A
N/A | 81667009(L)
6806637(S)
73408054(P) | 7.03(L)
0.58(S)
6.31(P) |
| 2020-07-15 | 歐雷強 | | 1711 (L) | N/A | N/A | 83554799(L) | 7.19(L) |
| 2020-07-15 | Baker Bros. Advisors (GP) LLC | | 1213 (L) | N/A | N/A | 173594207(L) | 14.92(L) |
| 2020-07-15 | Baker Brothers Life Sciences Capital, L.P. | | 1213 (L) | N/A | N/A | 159235478(L) | 13.69(L) |
| 2020-07-15 | 摩根大通 | 152.361 | 1213 (L)
N/A
N/A | 1,155,216(L)
N/A
N/A | N/A
N/A
N/A | 80376409(L)
6644185(S)
72951468(P) | 6.91(L)
0.57(S)
6.28(P) |
| 2020-07-15 | 富達投資 | | 1213 (L) | N/A | N/A | 73517402(L) | 6.33(L) |
| 2020-07-15 | 資本集團 | 0.000 | 1213 (L) | 661,102(L) | N/A | 100858645(L) | 8.68(L) |
| 2020-07-15 | Amgen Inc. | | 1213 (L) | 29,614,832(L) | N/A | 236249845(L) | 20.31(L) |
| 2020-07-15 | Baker Felix James | | 1213 (L) | N/A | N/A | 174056354(L) | 14.96(L) |
| 2020-07-15 | Baker Julian Charles | | 1213 (L) | N/A | N/A | 174056354(L) | 14.96(L) |
| 2020-07-13 | Amgen Inc. | | 1113 (L) | 29,614,832(L) | N/A | 236249845(L) | 23.22(L) |